A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 506 participants.

Also called NCT02630706

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 506 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02630706
Other papers using this trial's data
  • Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia Diabetes, obesity & metabolism, 2019-06 DOI, PubMed 30830724, PMC7379575 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02630706. Randomized; double masking; primary purpose treatment. Start 2015-12-16 (actual); primary completion 2017-12-27 (actual). Results posted on 2018-12-07.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Ertugliflozin 5 mg
Intervention (Drug)
Ertugliflozin 15 mg
Intervention (Drug)
Placebo matching ertugliflozin
Intervention (Drug)
Metformin
Intervention (Drug)
Glimepiride
Lead sponsor
Merck Sharp & Dohme LLC (class: industry)
Collaborator
Pfizer (class: industry)

Record details

Record id
cardio:ct-nct02630706
Content hash
b75da482a3b77aa27ae16ffebbdb6b78c6f75034fa9e36fc4c119cd31a4bdd44